VIVO Cannabis Inc. (OTCMKTS: VVCIF) has announced the signing of a distribution agreement with Australia’s leading medical cannabis distributor Burleigh Head Cannabis Pty Ltd.
The first shipment from VIVO expected in June
The distribution agreement is expected to make it easier for Australian patients to access VIVO’s high-quality medical cannabis oil, flower as well as other products through approved channels. The Australian Office of Drug and Control has already issued the necessary regulatory permits for the shipment of the first batch of cannabis products under the agreement. Burleigh Heads is expecting to get the first VIVO products shipment in June but that will be subject to VIVO receiving an export permit to allow shipment.
VIVO CEO Barry Fishman has indicated that they are very pleased to announce the signing of the distribution agreement that will provide the company with increased exposure in the Australian market as well as enhance consumer product and brand awareness. He added that Burleigh Head is a big supporter of enhanced patient access to safe medical cannabis through its affiliate CDA Clinics Australia. The company is a leading provider to Australian patients through channels of acquiring premium cannabis products.
Bringing Medical Cannabis as a treatment option near Australian patients
Burleigh Head Operations Director Guy Headley stated that they are impressed with the commitment of VIVO in producing a quality product and enhancing patient access. He added that the company is looking forward to offering Australian Patients and doctors with premium Medical cannabis as a treatment option. Headley indicated that the company was looking forward to working with VIVO whose product portfolio is exclusively expanding.
VIVO is based in Napanee in Ontario and it is a holder of production and sales licenses from Health Canada. The company operates state of the art indoor cultivation facilities that use novel plant-growing technology. The company has an assortment of premium brands that target exclusive customers segments which include Fireside, Beacon Medical, Lumina and Canna Farm. Currently, VIVO is expanding its production capacity as well as pursuing various partnerships and product development opportunities locally and in international markets like Australia and German.